Patient risk factors and pegfilgrastim use in cabazitaxel-treated prostate cancer pateints in an academic setting.
Marina Dusevic Kaymakcalan
No relevant relationships to disclose
Sherri Stuver
No relevant relationships to disclose
Christopher Sweeney
No relevant relationships to disclose
Toni K. Choueiri
No relevant relationships to disclose
Aymen Elfiky
No relevant relationships to disclose